Cel We will develop gene therapy approaches for wiskott-Aldrich syndrome, based on ex vivo transduction of T lymphocytes or hematopoietic progenitors with retroviral vectors. Efficacy and safety will be assessed in preclinical studies. Dziedzina nauki medical and health sciencesmedical biotechnologygenetic engineeringgene therapy Program(-y) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Temat(-y) 1.1.1.-2. - Key action Control of Infectious Diseases Zaproszenie do składania wniosków Data not available System finansowania RGI - Research grants (individual fellowships) Koordynator FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR - ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO Wkład UE Brak danych Adres Via Olgettina 58 20132 MILANO Włochy Zobacz na mapie Koszt całkowity Brak danych